Rothschild Investment Corp Athira Pharma, Inc. Transaction History
Rothschild Investment Corp
- $1.19 Billion
- Q3 2023
A detailed history of Rothschild Investment Corp transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Rothschild Investment Corp holds 33,600 shares of ATHA stock, worth $154,896. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,600
Previous 33,600
-0.0%
Holding current value
$154,896
Previous $99,000
31.31%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ATHA
# of Institutions
11Shares Held
1.34MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY676KShares$3.12 Million0.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ425KShares$1.96 Million0.01% of portfolio
-
Potomac Capital Management, Inc.150KShares$689,5860.64% of portfolio
-
Invst, LLC Indianapolis, IN45KShares$207,4500.0% of portfolio
-
Lindbrook Capital, LLC8.92KShares$41,1210.0% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $174M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...